{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:07:11Z","timestamp":1790701631609,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.neulet.2021.135661","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T11:25:18Z","timestamp":1611055518000},"page":"135661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Opioids and cancer prognosis: A summary of the clinical evidence"],"prefix":"10.1016","volume":"746","author":[{"given":"Maria F.","family":"Ramirez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gorur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan P.","family":"Cata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2021.135661_bib0005","first-page":"567","article-title":"Opium as a risk factor for bladder cancer: a population-based case-control study in Iran","volume":"18","author":"Akbari","year":"2015","journal-title":"Arch. Iran. Med."},{"key":"10.1016\/j.neulet.2021.135661_bib0010","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1089\/jpm.2010.0031","article-title":"Opioid use at the end of life and survival in a hospital at home unit","volume":"13","author":"Bengoechea","year":"2010","journal-title":"J. Palliat. Med."},{"key":"10.1016\/j.neulet.2021.135661_bib0015","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00228-019-02801-2","article-title":"The relationship between pain, analgesics and survival in patients with advanced cancer; a secondary data analysis of the international European palliative care cancer symptom study","volume":"76","author":"Boland","year":"2020","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.neulet.2021.135661_bib0020","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/ALN.0b013e31824b96a1","article-title":"Mu-opioid receptor gene A118G polymorphism predicts survival in patients with breast cancer","volume":"116","author":"Bortsov","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neulet.2021.135661_bib0025","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/pds.4779","article-title":"Risk of second breast cancer events with chronic opioid use in breast cancer survivors","volume":"28","author":"Boudreau","year":"2019","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.neulet.2021.135661_bib0030","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/cam4.236","article-title":"A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection","volume":"3","author":"Cata","year":"2014","journal-title":"Cancer Med."},{"key":"10.1016\/j.neulet.2021.135661_bib0035","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jclinane.2015.07.012","article-title":"Intraoperative opioids use for laryngeal squamous cell carcinoma surgery and recurrence: a retrospective study","volume":"27","author":"Cata","year":"2015","journal-title":"J. Clin. Anesth."},{"key":"10.1016\/j.neulet.2021.135661_bib0040","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejon.2014.11.007","article-title":"Use of opioid analgesics or sleeping medication and survival of cancer patients","volume":"19","author":"Chang","year":"2015","journal-title":"Eur. J. Oncol. Nurs."},{"key":"10.1016\/j.neulet.2021.135661_bib0045","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/j.bja.2018.09.030","article-title":"The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target","volume":"122","author":"Chen","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neulet.2021.135661_bib0050","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1007\/s13277-015-3113-z","article-title":"Mu-opioid receptor gene (OPRM1) polymorphism in patients with breast cancer","volume":"36","author":"Cieslinska","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.neulet.2021.135661_bib0055","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2217\/pmt-2018-0029","article-title":"Perioperative opioids and colorectal cancer recurrence: a systematic review of the literature","volume":"8","author":"Diaz-Cambronero","year":"2018","journal-title":"Pain Manag."},{"key":"10.1016\/j.neulet.2021.135661_bib0060","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010134","article-title":"Mu opioid receptor 1 (MOR-1) expression in colorectal Cancer and oncological long-term outcomes: a five-year retrospective longitudinal cohort study","volume":"12","author":"Diaz-Cambronero","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.neulet.2021.135661_bib0065","first-page":"1906","article-title":"Role of opium in esophageal cancer: a hypothesis","volume":"45","author":"Dowlatshahi","year":"1985","journal-title":"Cancer Res."},{"key":"10.1016\/j.neulet.2021.135661_bib0070","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1213\/ANE.0000000000003428","article-title":"Effects of intraoperative opioid use on recurrence-free and overall survival in patients with esophageal adenocarcinoma and squamous cell carcinoma","volume":"127","author":"Du","year":"2018","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neulet.2021.135661_bib0075","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1016\/j.pain.2014.07.006","article-title":"Chronic pain, opioid prescriptions, and mortality in Denmark: a population-based cohort study","volume":"155","author":"Ekholm","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.neulet.2021.135661_bib0080","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/EJA.0b013e32834b7d9a","article-title":"Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer?","volume":"28","author":"Forget","year":"2011","journal-title":"Eur. J. Anaesthesiol."},{"key":"10.1016\/j.neulet.2021.135661_bib0085","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1139\/O08-001","article-title":"Opioid-induced regulation of mu-opioid receptor gene expression in the MCF-7 breast cancer cell line","volume":"86","author":"Gach","year":"2008","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.neulet.2021.135661_bib0090","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/ijc.2910350505","article-title":"Oesophageal cancer studies in the Caspian littoral of Iran: some residual results, including opium use as a risk factor","volume":"35","author":"Ghadirian","year":"1985","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.neulet.2021.135661_bib0095","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.drugalcdep.2011.05.028","article-title":"Methadone maintenance and cancer risk: an Israeli case registry study","volume":"119","author":"Grinshpoon","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neulet.2021.135661_bib0100","first-page":"4491","article-title":"Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth","volume":"62","author":"Gupta","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.neulet.2021.135661_bib0105","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1089\/jpm.2018.0044","article-title":"Opioid dose and survival of patients with incurable nonsmall cell lung cancer: a prospective cohort study","volume":"21","author":"Hasegawa","year":"2018","journal-title":"J. Palliat. Med."},{"key":"10.1016\/j.neulet.2021.135661_bib0110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrclinonc.2017.194","article-title":"Perioperative events influence cancer recurrence risk after surgery","volume":"15","author":"Hiller","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.neulet.2021.135661_bib0115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3892\/mco.2012.16","article-title":"Prognostic significance of opioid use in the active treatment of advanced colorectal cancer","volume":"1","author":"Inoue","year":"2013","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.neulet.2021.135661_bib0120","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3344\/kjp.2020.33.2.108","article-title":"All about pain pharmacology: what pain physicians should know","volume":"33","author":"Kim","year":"2020","journal-title":"Korean J. Pain"},{"key":"10.1016\/j.neulet.2021.135661_bib0125","doi-asserted-by":"crossref","first-page":"984","DOI":"10.2353\/ajpath.2010.090621","article-title":"Morphine suppresses tumor angiogenesis through a HIF-1alpha\/p38MAPK pathway","volume":"177","author":"Koodie","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neulet.2021.135661_bib0130","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00277-013-1861-7","article-title":"Patients with malignant hematological disorders treated on a palliative care unit: prognostic impact of clinical factors","volume":"93","author":"Kripp","year":"2013","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.neulet.2021.135661_bib0135","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13046-018-0674-x","article-title":"Role of the nervous system in cancer metastasis","volume":"37","author":"Kuol","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.neulet.2021.135661_bib0140","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/ALN.0b013e31824b9512","article-title":"The mu-opioid receptor in cancer progression: is there a direct effect?","volume":"116","author":"Lennon","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neulet.2021.135661_bib0145","first-page":"1033","article-title":"Opioids induce while nicotine suppresses apoptosis in human lung cancer cells","volume":"5","author":"Maneckjee","year":"1994","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.neulet.2021.135661_bib0150","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000338559","article-title":"Opium could be considered an independent risk factor for lung cancer: a case-control study","volume":"85","author":"Masjedi","year":"2013","journal-title":"Respiration"},{"key":"10.1016\/j.neulet.2021.135661_bib0155","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1213\/ANE.0b013e31820568af","article-title":"The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation","volume":"112","author":"Mathew","year":"2011","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neulet.2021.135661_bib0160","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1213\/ANE.0b013e31820568af","article-title":"The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation","volume":"112","author":"Mathew","year":"2011","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neulet.2021.135661_bib0165","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1016\/j.bja.2019.03.023","article-title":"Chronic pain: a review of its epidemiology and associated factors in population-based studies","volume":"123","author":"Mills","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neulet.2021.135661_bib0170","first-page":"2245","article-title":"Opioids have no negative effect on the survival time of patients with advanced lung cancer in an acute care hospital","volume":"23","author":"Minami","year":"2015","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.neulet.2021.135661_bib0175","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7525-7-102","article-title":"Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008","volume":"7","author":"Montazeri","year":"2009","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.neulet.2021.135661_bib0180","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1097\/00005537-200311000-00016","article-title":"Opium and risk of laryngeal cancer","volume":"113","author":"Mousavi","year":"2003","journal-title":"Laryngoscope"},{"key":"10.1016\/j.neulet.2021.135661_bib0185","first-page":"2","article-title":"Opium as a risk factor for upper gastrointestinal cancers: a population-based case-control study in Iran","volume":"17","author":"Naghibzadeh Tahami","year":"2014","journal-title":"Arch. Iran. Med."},{"key":"10.1016\/j.neulet.2021.135661_bib0190","doi-asserted-by":"crossref","DOI":"10.1097\/j.pain.0000000000001630","article-title":"Persistent opioid use is associated with worse survival after lobectomy for stage i non-small cell lung cancer","author":"Nelson","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.neulet.2021.135661_bib0195","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4048\/jbc.2016.19.2.206","article-title":"Mu-opioid receptor polymorphisms and breast Cancer in a Korean female adult population: a retrospective study","volume":"19","author":"Oh","year":"2016","journal-title":"J. Breast Cancer"},{"key":"10.1016\/j.neulet.2021.135661_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/dote\/dox074","article-title":"Association of high-dose postoperative opioids with recurrence risk in esophageal squamous cell carcinoma: reinterpreting ERAS protocols for long-term oncologic surgery outcomes","volume":"30","author":"Oh","year":"2017","journal-title":"Dis. Esophagus"},{"key":"10.1016\/j.neulet.2021.135661_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.oraloncology.2017.09.006","article-title":"The impact of intraoperative opioid use on survival after oral cancer surgery","volume":"74","author":"Patino","year":"2017","journal-title":"Oral Oncol."},{"key":"10.1016\/j.neulet.2021.135661_bib0210","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/toxsci\/kfy184","article-title":"The evolution of carcinogenesis","volume":"165","author":"Peters","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.neulet.2021.135661_bib0215","doi-asserted-by":"crossref","first-page":"e505","DOI":"10.1097\/SCS.0000000000001089","article-title":"Opium usage as an etiologic factor of oral cavity cancer","volume":"25","author":"Razmpa","year":"2014","journal-title":"J. Craniofac. Surg."},{"key":"10.1016\/j.neulet.2021.135661_bib0220","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ijc.28344","article-title":"Neglected role of hookah and opium in gastric carcinogenesis: a cohort study on risk factors and attributable fractions","volume":"134","author":"Sadjadi","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.neulet.2021.135661_bib0225","doi-asserted-by":"crossref","DOI":"10.1186\/s12904-016-0169-5","article-title":"The association between different opioid doses and the survival of advanced cancer patients receiving palliative care","volume":"15","author":"Sathornviriyapong","year":"2016","journal-title":"BMC Palliat. Care"},{"key":"10.1016\/j.neulet.2021.135661_bib0230","doi-asserted-by":"crossref","first-page":"e649","DOI":"10.1016\/S2214-109X(20)30059-0","article-title":"Opium use and subsequent incidence of cancer: results from the Golestan Cohort Study","volume":"8","author":"Sheikh","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.neulet.2021.135661_bib0235","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1200\/JCO.2002.02.118","article-title":"Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival","volume":"20","author":"Smith","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neulet.2021.135661_bib0240","doi-asserted-by":"crossref","DOI":"10.1097\/COC.0000000000000714","article-title":"Impact of pain, opioids, and the mu-opioid receptor on progression and survival in patients with newly diagnosed stage IV pancreatic cancer","author":"Steele","year":"2020","journal-title":"Am. J. Clinical Oncol."},{"key":"10.1016\/j.neulet.2021.135661_bib0245","doi-asserted-by":"crossref","first-page":"10816","DOI":"10.1038\/s41598-017-11460-1","article-title":"Intraoperative fentanyl consumption does not impact cancer recurrence or overall survival after curative colorectal cancer resection","volume":"7","author":"Tai","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neulet.2021.135661_bib0250","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10549-017-4348-8","article-title":"Opioid use among female breast cancer patients using different adjuvant endocrine therapy regimens","volume":"165","author":"Tan","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.neulet.2021.135661_bib0255","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s10147-012-0441-5","article-title":"Polymorphism of A118G in mu-opioid receptor gene is associated with risk of esophageal squamous cell carcinoma in a Chinese population","volume":"18","author":"Wang","year":"2013","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.neulet.2021.135661_bib0260","article-title":"Does postoperative morphine consumption for acute surgical pain impact oncologic outcomes after colorectal cancer resection?: a retrospective cohort study","volume":"98","author":"Wu","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.neulet.2021.135661_bib0265","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22018","article-title":"A118G polymorphism in mu-opioid receptor gene and interactions with smoking and drinking on risk of oesophageal squamous cell carcinoma","volume":"31","author":"Xu","year":"2017","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.neulet.2021.135661_bib0270","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/cts.12246","article-title":"MOR1 expression in gastric cancer: a biomarker associated with poor outcome","volume":"8","author":"Yao","year":"2015","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.neulet.2021.135661_bib0275","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jama.284.11.1383","article-title":"Oral methylnaltrexone for opioid-induced constipation","volume":"284","author":"Yuan","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.neulet.2021.135661_bib0280","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.bja.2020.07.051","article-title":"Increased mu-opioid receptor expression is associated with reduced disease-free and overall survival in laryngeal squamous cell carcinoma","volume":"125","author":"Zhang","year":"2020","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neulet.2021.135661_bib0285","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/dote.12165","article-title":"Association of mu-opioid receptor expression with lymph node metastasis in esophageal squamous cell carcinoma","volume":"28","author":"Zhang","year":"2015","journal-title":"Dis. Esophagus"},{"key":"10.1016\/j.neulet.2021.135661_bib0290","article-title":"The impact of pain and opioids use on survival in cancer patients: results from a population-based cohort study and a meta-analysis","volume":"99","author":"Zheng","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.neulet.2021.135661_bib0295","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1002\/cncr.28345","article-title":"Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer","volume":"119","author":"Zylla","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.neulet.2021.135661_bib0300","doi-asserted-by":"crossref","first-page":"i109","DOI":"10.1093\/bja\/aeu351","article-title":"Association of opioid requirement and cancer pain with survival in advanced non-small cell lung cancer","volume":"113","author":"Zylla","year":"2014","journal-title":"Br. J. Anaesth."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394021000392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394021000392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:37:13Z","timestamp":1759610233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394021000392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":60,"alternative-id":["S0304394021000392"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2021.135661","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioids and cancer prognosis: A summary of the clinical evidence","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2021.135661","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"135661"}}